Meeting
2018 ASCO Quality Care Symposium
A data driven approach to immunotherapy toxicity management.
Authors
Sadiqa Mahmood
Dana-Farber Cancer Institute, Boston, MA
Sadiqa Mahmood, Eli Schwamm, Kenneth L. Kehl, Brett Glotzbecker, Robert Andrews, Prabhsimranjot Singh, Belen Fraile, Andrew J. Wagner, Joseph O. Jacobson, Nicole R. LeBoeuf, Osama E. Rahma, Shobana Muthulingam
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Projects Relating to Patient Experience; Projects Relating to Safety; Technology and Innovation in Quality of Care
Track
Projects Relating to Patient Experience,Projects Relating to Safety,Technology and Innovation in Quality of Care
Sub Track
Use of IT/Analytics to Improve Quality
Citation
J Clin Oncol 36, 2018 (suppl 30; abstr 326)
DOI
10.1200/JCO.2018.36.30_suppl.326
Abstract #
326
Poster Bd #
Q6
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Comparing rates of immune checkpoint inhibitor toxicity in different treatment settings (neoadjuvant, adjuvant, and palliative) in non-small cell lung cancer (NSCLC): A meta-analysis of phase III clinical trials.
First Author: Carolyn Moloney
Poster
2022 ASCO Annual Meeting
Comparing rate of immunotherapy treatment change due to toxicity by gender.
First Author: Kevin Joseph Chua
Poster
2022 ASCO Genitourinary Cancers Symposium
Distribution of immune-related adverse events (irAEs) across genitourinary (GU) malignancies.
First Author: Nataliya Mar
Poster
2019 ASCO Annual Meeting
Cardiovascular complications of immune checkpoint inhibitor therapy.
First Author: Samip R. Master